FSD Pharma ( (#Nasdaq: $HUGE | #CSE: $HUGE) Receives U.S. FDA Approval to design a Phase 2a #ClinicalTrial to Treat Patients with Suspected or Confirmed #COVID19 Diagnosis [  #investing #stocks #stockmarket #trading #investors #news #coronavirus